115
Views
14
CrossRef citations to date
0
Altmetric
Original Investigations

Use of aripiprazole in tardive dyskinesia: An open label study of six cases

, , , , & , MD
Pages 416-419 | Received 25 Feb 2009, Published online: 08 Dec 2009

References

  • Abbasian, C, Power, P. 2009. A case of aripiprazole and tardive dyskinesia. J Psychopharmacol Mar;23(2)214–5. Epub 2008 May 30.
  • Casey D. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 1999; 35(Suppl)S61–66
  • Casey D. Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 2004; 65(Suppl 9)25–28
  • Correll C, Schenk E. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008; 21(2)151–156
  • Duggal H, Mendhekar D. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors. Am J Psychiatry 2006; 163(8)1449–1450
  • Fleischhacker W, Lemmens P, van Baelen B. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Pharmacopsychiatry 2001; 34(3)104–110
  • Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004; 65(Suppl 9)16–20
  • Kantrowitz JT, Srihari V, Tek. Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. J Clin Psychopharmacol 2007; 27(5)525–526
  • Lim HK, Pae CU, Lee C, Lee. Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(2)589–590
  • Lykouras L, Rizos E, Gournellis R. Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(7)1535–1536
  • Miller del, D, Eudicone, JM, Pikalov, A, Kim. 2007. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. J Clin Psychiatry, 68(12)1901–1906.
  • Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982; 39(4)486–487
  • Sharma A, Ramaswamy S, Dewan VK. Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry 2005; 7(1)36
  • Soares-Weiser K, Fernandez HH. Tardive dyskinesia. Semin Neurol 2007; 27(2)159–169
  • Tandon, R, Jibson, MD. 2001. Pharmacologic treatment of schizophrenia: what the future holds. CNS Spectr, 6(12):980–984, 986.
  • Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord 2006; 21(5)589–598

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.